Robert W Regenhardt1, Adam P Mecca2, Stephanie A Flavin3, Gregoire Boulouis1, Arne Lauer1, Kori Sauser Zachrison3, James Boomhower4, Aman B Patel5,6, Joshua A Hirsch6, Lee H Schwamm1, Thabele M Leslie-Mazwi7,5,6. 1. From the Department of Neurology (R.W.R., G.B., A.L., L.H.S., T.M.L.-M.). 2. Department of Psychiatry, Yale New Haven Hospital, CT (A.P.M.). 3. Department of Emergency Medicine (S.A.F., K.S.Z.). 4. Boston MedFlight, MA (J.B.). 5. Department of Neurosurgery (A.B.P., T.M.L.-M.). 6. Neuroendovascular Service (A.B.P., J.A.H., T.M.L.-M.), Massachusetts General Hospital, Boston. 7. From the Department of Neurology (R.W.R., G.B., A.L., L.H.S., T.M.L.-M.) tleslie-mazwi@mgh.harvard.edu.
Abstract
BACKGROUND AND PURPOSE: For suspected large vessel occlusion patients efficient transfer to centers that provide endovascular therapy (ET) is critical to maximizing treatment opportunity. Our objective was to examine associations between transfer time, modes of transfer, ET, and outcomes within a hub-and-spoke telestroke network. METHODS: Patients with ischemic stroke were included if transferred to a single hub hospital between January 2011 and October 2015 with National Institutes of Health Stroke Scale>6, onset<12 hours from hub arrival with complete clinical, imaging, and transfer data. Transfer time was the interval between initiation of telestroke consult and arrival at the hub. Algorithms were created for ideal transfer times; ideal time was subtracted from actual time to calculate delay. We examined bivariate relationships between transfer time and several clinical outcomes and used multivariable regression modeling to explore possible predictors of delay. RESULTS: Of 234 patients that met inclusion criteria, 51% were transferred by ambulance and 49% by helicopter; 27% underwent ET (36% achieved modified Rankin Scale score of 0-2 at 90 days). Median actual transfer time was 132 minutes (interquartile range, 103-165), compared with median ideal transfer time at 102 minutes (interquartile range, 96-123). Longer transfer time was associated with decreased likelihood of undergoing ET (odds ratio, 0.990; P=0.003). Nocturnal transfer (18:00 to 06:00 hours) was associated with significantly longer delay (β=20.5; P<0.0005), whereas intravenous tissue-type plasminogen activator (tPA) delivery at spoke hospital was not. The median delay for nocturnal transfer was 31 minutes (interquartile range, 11-51), compared with daytime at 14 minutes (interquartile range, -9 to 36). CONCLUSIONS: Within a large telestroke network, there was an association between longer transfer time and decreased likelihood of undergoing ET. Nocturnal transfers were associated with a substantial delay relative to daytime transfers. In contrast, delivery of tPA was not associated with delays, underscoring the impact of effective protocols at spoke hospitals. More efficient transfer may enable higher ET treatment rates. Metrics and protocols for transfer, especially at night, may improve transfer times.
BACKGROUND AND PURPOSE: For suspected large vessel occlusion patients efficient transfer to centers that provide endovascular therapy (ET) is critical to maximizing treatment opportunity. Our objective was to examine associations between transfer time, modes of transfer, ET, and outcomes within a hub-and-spoke telestroke network. METHODS:Patients with ischemic stroke were included if transferred to a single hub hospital between January 2011 and October 2015 with National Institutes of Health Stroke Scale>6, onset<12 hours from hub arrival with complete clinical, imaging, and transfer data. Transfer time was the interval between initiation of telestroke consult and arrival at the hub. Algorithms were created for ideal transfer times; ideal time was subtracted from actual time to calculate delay. We examined bivariate relationships between transfer time and several clinical outcomes and used multivariable regression modeling to explore possible predictors of delay. RESULTS: Of 234 patients that met inclusion criteria, 51% were transferred by ambulance and 49% by helicopter; 27% underwent ET (36% achieved modified Rankin Scale score of 0-2 at 90 days). Median actual transfer time was 132 minutes (interquartile range, 103-165), compared with median ideal transfer time at 102 minutes (interquartile range, 96-123). Longer transfer time was associated with decreased likelihood of undergoing ET (odds ratio, 0.990; P=0.003). Nocturnal transfer (18:00 to 06:00 hours) was associated with significantly longer delay (β=20.5; P<0.0005), whereas intravenous tissue-type plasminogen activator (tPA) delivery at spoke hospital was not. The median delay for nocturnal transfer was 31 minutes (interquartile range, 11-51), compared with daytime at 14 minutes (interquartile range, -9 to 36). CONCLUSIONS: Within a large telestroke network, there was an association between longer transfer time and decreased likelihood of undergoing ET. Nocturnal transfers were associated with a substantial delay relative to daytime transfers. In contrast, delivery of tPA was not associated with delays, underscoring the impact of effective protocols at spoke hospitals. More efficient transfer may enable higher ET treatment rates. Metrics and protocols for transfer, especially at night, may improve transfer times.
Authors: F Akbik; J A Hirsch; R V Chandra; D Frei; A B Patel; J D Rabinov; N Rost; L H Schwamm; T M Leslie-Mazwi Journal: J Neurointerv Surg Date: 2016-03-16 Impact factor: 5.836
Authors: Mayank Goyal; Bijoy K Menon; Wim H van Zwam; Diederik W J Dippel; Peter J Mitchell; Andrew M Demchuk; Antoni Dávalos; Charles B L M Majoie; Aad van der Lugt; Maria A de Miquel; Geoffrey A Donnan; Yvo B W E M Roos; Alain Bonafe; Reza Jahan; Hans-Christoph Diener; Lucie A van den Berg; Elad I Levy; Olvert A Berkhemer; Vitor M Pereira; Jeremy Rempel; Mònica Millán; Stephen M Davis; Daniel Roy; John Thornton; Luis San Román; Marc Ribó; Debbie Beumer; Bruce Stouch; Scott Brown; Bruce C V Campbell; Robert J van Oostenbrugge; Jeffrey L Saver; Michael D Hill; Tudor G Jovin Journal: Lancet Date: 2016-02-18 Impact factor: 79.321
Authors: Kevin N Sheth; Eric E Smith; Maria V Grau-Sepulveda; Dawn Kleindorfer; Gregg C Fonarow; Lee H Schwamm Journal: Stroke Date: 2015-02-11 Impact factor: 7.914
Authors: Mirjam R Heldner; Christoph Zubler; Heinrich P Mattle; Gerhard Schroth; Anja Weck; Marie-Luise Mono; Jan Gralla; Simon Jung; Marwan El-Koussy; Rudolf Lüdi; Xin Yan; Marcel Arnold; Christoph Ozdoba; Pasquale Mordasini; Urs Fischer Journal: Stroke Date: 2013-03-07 Impact factor: 7.914
Authors: Chung-Huan J Sun; Raul G Nogueira; Brenda A Glenn; Kerrin Connelly; Susan Zimmermann; Kim Anda; Deborah Camp; Michael R Frankel; Samir R Belagaje; Aaron M Anderson; Alexander P Isakov; Rishi Gupta Journal: Circulation Date: 2013-02-07 Impact factor: 29.690
Authors: Bart M Demaerschalk; Madeline L Miley; Terri-Ellen J Kiernan; Bentley J Bobrow; Doren A Corday; Kay E Wellik; Maria I Aguilar; Timothy J Ingall; David W Dodick; Karina Brazdys; Tiffany C Koch; Michael P Ward; Phillip C Richemont Journal: Mayo Clin Proc Date: 2009 Impact factor: 7.616
Authors: Gregoire Boulouis; Arne Lauer; Ahmer Khawdja Siddiqui; Andreas Charidimou; Robert W Regenhardt; Anand Viswanathan; Natalia Rost; Thabele M Leslie-Mazwi; Lee H Schwamm Journal: JAMA Neurol Date: 2017-11-01 Impact factor: 18.302
Authors: Eyad Almallouhi; Sami Al Kasab; Michael Nahhas; Jillian B Harvey; Juanita Caudill; Nancy Turner; Ellen Debenham; Dan-Victor Giurgiutiu; Enrique C Leira; Jeffrey A Switzer; Christine A Holmstedt Journal: Neurol Clin Pract Date: 2020-10
Authors: Shreyansh Shah; Ying Xian; Shubin Sheng; Kori S Zachrison; Jeffrey L Saver; Kevin N Sheth; Gregg C Fonarow; Lee H Schwamm; Eric E Smith Journal: Circulation Date: 2019-03-26 Impact factor: 29.690
Authors: A T Yu; R W Regenhardt; C Whitney; L H Schwamm; A B Patel; C J Stapleton; A Viswanathan; J A Hirsch; M Lev; T M Leslie-Mazwi Journal: AJNR Am J Neuroradiol Date: 2021-02-04 Impact factor: 3.825
Authors: Robert W Regenhardt; R Gilberto González; Julian He; Michael H Lev; Aneesh B Singhal Journal: Radiology Date: 2021-11-02 Impact factor: 11.105
Authors: Robert W Regenhardt; Mark R Etherton; Alvin S Das; Markus D Schirmer; Joshua A Hirsch; Christopher J Stapleton; Aman B Patel; Thabele M Leslie-Mazwi; Natalia S Rost Journal: J Stroke Cerebrovasc Dis Date: 2020-12-29 Impact factor: 2.136
Authors: Neal M Nolan; Robert W Regenhardt; Matthew J Koch; Scott B Raymond; Christopher J Stapleton; James D Rabinov; Scott B Silverman; Thabele M Leslie-Mazwi; Aman B Patel Journal: J Stroke Cerebrovasc Dis Date: 2020-11-26 Impact factor: 2.136
Authors: Robert W Regenhardt; Mark R Etherton; Alvin S Das; Markus D Schirmer; Joshua A Hirsch; Christopher J Stapleton; Aman B Patel; Thabele M Leslie-Mazwi; Natalia S Rost Journal: J Neuroimaging Date: 2020-10-29 Impact factor: 2.486